Which medications in the drug class Antineoplastics, VEGF Inhibitor are used in the treatment of Gastric Cancer?

Updated: Feb 23, 2021
  • Author: Elwyn C Cabebe, MD; Chief Editor: N Joseph Espat, MD, MS, FACS  more...
  • Print

Antineoplastics, VEGF Inhibitor

Vascular endothelial growth factor inhibitors reduce tumor vascularity and growth.

Ramucirumab (Cyramza)

Ramucirumab is a monoclonal antibody that inhibits activation of vascular endothelial growth factor receptor 2 (VEGFR2). Has high affinity for VEGFR2 binding and blocks binding of VEFGR ligands, VEGF-A, VEGF-C and VEGF-D.  

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!